Specific detection of high mobility group box 1 degradation product with a novel ELISA.
Takaaki TotokiTakashi ItoShingo YamadaGoichi HondaTsuyoshi HattoriIkuro MaruyamaPublished in: Molecular medicine (Cambridge, Mass.) (2021)
In this study, we obtained a desHMGB1-specific monoclonal antibody. ELISA using the novel monoclonal antibody may be an option for the in-depth analysis of HMGB1-induced pathogenicity as well as rTM-mediated therapeutic efficiency.